For citations:
Kushlinskii N.E., Kulikova S.E., Gugnin F.A., Nezhdanova S.Yu., Gratchev A.N., Utkin D.O., Tsekatunov D.A., Ryzhavskaya I.B., Kushlinskiy D.N., Gershtein E.S., Stilidi I.S. Clinical and laboratory significance of soluble claudin-5 and VEGF in ovarian cancer. Advances in Molecular Oncology. 2025;12(1):67-75. (In Russ.) https://doi.org/10.17650/2313-805X-2025-12-1-67-75
Email this article 